Clinical features | High STC1 (n = 38) | Low STC1 (n = 34) | P-value |
---|---|---|---|
Age | Â | Â | Â |
 Young (≤ median, 52) | 23 | 19 | 0.83 |
 Old (> medium, 52) | 15 | 15 |  |
Gender | Â | Â | Â |
 Male | 32 | 29 | 0.35 |
 Female | 6 | 5 |  |
Overall survival, median, months | 18.5Â months | 37Â months | 0.0051** |
HBsAg | Â | Â | Â |
 Negative | 10 | 7 | 0.28 |
 Positive | 28 | 27 |  |
Serum AFP (ng/ml) | Â | Â | Â |
 Low (≤ 20) | 15 | 12 | 0.32 |
 High (> 20) | 23 | 22 |  |
Differentiation status | Â | Â | Â |
 Well differentiation | 9 | 13 | 0.08 |
 Moderately to poorly differentiation | 29 | 21 |  |
Tumor size | Â | Â | Â |
 Small (≤ 5 cm) | 7 | 10 | 0.17 |
 Large (> 5 cm) | 31 | 24 |  |
TNM stagea | Â | Â | Â |
 Early stage (I–II) | 27 | 26 | 0.011* |
 Advanced stage (III–IV) | 11 | 8 |  |
Lymph node metastasis | Â | Â | Â |
 Absence | 29 | 30 | 0.75 |
 Presence | 9 | 4 |  |
Vascular infiltration | Â | Â | Â |
 Absence | 30 | 32 | 0.26 |
 Presence | 8 | 2 |  |